Who Paid My Doc
Acp-103-069
ClinicalTrials.gov NCT05523895
Research payments
$3,936,375
Through program year 2025, $3,936,375 in research payments was reported against Acp-103-069, across 319 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT05523895
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $542,937 | 55 |
| 2024 | Research | $1,477,943 | 120 |
| 2023 | Research | $1,793,693 | 130 |
| 2022 | Research | $121,801 | 14 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Elias Sarkis Gainesville, FL Named on 27 payments
- Bradley Musser Richardson, TX Named on 24 payments
- Morteza Nadjafi Orlando, FL Named on 24 payments
- James Knutson Kirkland, WA Named on 23 payments
- Isaac Melamed Centennial, CO Named on 21 payments
- Raun Melmed Scottsdale, AZ Named on 19 payments
- Riaz Baber Naperville, IL Named on 19 payments
- Ernest Pedapati Cincinnati, OH Named on 19 payments
- Elysa Marco San Francisco, CA Named on 15 payments
- Amanda Bennett Philadelphia, PA Named on 13 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.